4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-039035
Chief Medical Officer sold 4,000 shares at an average $33.60 ($134,387)
- Chief Medical Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Alland Leila · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-07 | Exercise or conversion : show line 1 in the form | +4,000 | $3.90 | $15,600 | 4,000 | D |
| 2021-06-07 | Sale : show line 2 in the form | −2,633 | $33.39 | $87,903 | 1,367 | D |
| 2021-06-07 | Sale : show line 3 in the form | −1,367 | $34.00 | $46,484 | 0 | D |
| Open-market sales · 4,000 sh · avg $33.60 · $134,387 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-12 | Grant or award : show line 4 in the form Employee Stock Option (right to buy) | +36,279 | 36,279 | D |
| 2021-06-07 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −4,000 | 365,850 | D |
Loading xslF345X03/doc4.xml…